Otonomy has chalked up its second clinical trial failure in the space of a few months, the latest in a mid-stage study of a treatment for hearing loss, and the biotech has now been forced into a ...
Regeneron’s gene therapy for otoferlin-related hearing loss – a genetic cause of deafness – has restored hearing to normal levels in one profoundly deaf child within just 24 weeks. The result comes ...
Ngày 4/6, BYD Việt Nam ra mắt crossover thuần điện cỡ B Atto 2 đến thị trường Việt Nam. Xe có tầm hoạt động 380 km cho một lần sạc, môtơ cầu trước mạnh 174 mã lực, giá 669 triệu đồng. Đây là mẫu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results